📌 Key Takeaways
- Topic: Fumed Silica Market 2026: Size, Growth, Key Players and Forecast
- Keywords: talc powder
- Published: 2026-11-20 00:22:20
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Sibelco Quartz: Product Range, Purity Grades and Applications
- What Is Mesoporous Silica? Structure, Pore Size and Applications in Drug Delivery and Catalysis
- Silicone vs Silica: What Is the Difference and Where Is Each Used?
- Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
- Silica as a Reinforcing Agent: How It Improves Strength in Rubber and Polymers
- 82. Kumarasamy R.V., Natarajan P.M., Umapathy V.R., Roy J.R., Mironescu M., Palanisamy C.P. Clinical applications and therapeutic potentials of advanced nanoparticles: A comprehensive review on completed human clinical trials. Front. Nanotechnol. 2024;6:1479993. doi: 10.3389/fnano.2024.1479993. [ DOI ] [ Google Scholar ]
- Custom Silica: Tailoring Particle Size, Surface Treatment and Purity to Your Application
- Employing DE For Health Benefits
How to Choose a Silica Manufacturer: Capacity, Quality Control and Certifications
What is silica (SiO₂)?
dental grade silica
What is the difference between fumed silica and precipitated silica?
low CTE filler 91. Pamshong S.R., Bhatane D., Sarnaik S., Alexander A. Mesoporous silica nanoparticles: An emerging approach in overcoming the challenges with oral delivery of proteins and peptides. Colloids Surf. B Biointerfaces. 2023;232:113613. doi: 10.1016/j.colsurfb.2023.113613. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
Tosoh silica Loading the drug into mesoporous carriers can be beneficial since aqueous solubility may boost and a more favorable dissolution profile can be achieved during application, resulting in higher oral bioavailability [ 36, 42 ]. The sizable particular surface area of the carriers favors amorphization, and the narrow spaces of the pores stop crystallization [ 3, 20, 43 ], since if the pores are tiny enough, it is thermodynamically more favorable for the API to remain in an amorphous state, thereby stabilizing its state [ 20 ]. The amorphous state is associated with higher Gibbs free energy and a higher degree of molecular mobility than the crystalline state [ 3, 36 ], resulting in boosted solubility compared to the crystalline form [ 3 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.